The facility has dedicated manufacturing and packaging for oral solid dosage forms, liquids, creams, and ointments.
Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, announced on June 20, 2020 that it has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility in Sellersville, PA.
The 221,000-ft2 facility has dedicated manufacturing and packaging technologies for oral solid dosage forms, liquids, creams, and ointments; quality control and microbiology labs; preformulation and analytical development infrastructure, with a pilot lab for research and development; and a temperature-controlled warehouse, according to a company press release. PPS plans to introduce the site to high potency drug manufacturing along with support development services and COVID-19 management drug opportunities.
“Many of our customers are looking for US-based manufacturing partners to expand and support their pipeline. This acquisition strengthens our ability to partner with them … and adds solid oral dosage capability in the US. We now offer solid oral drug product development and commercial manufacturing in all our major geographies, addressing a previously unmet customer need and strengthening our ability to work globally with customers to reduce the burden of disease on patients,” said Peter DeYoung, CEO, Piramal Pharma Solutions, in the press release.
Source: PPS
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.